Telad Competitors

Hims & Hers Health, Inc. is the leading global health and wellness platform, connecting people to independent, licensed healthcare providers to build the future of everyday health. We're on a mission to help the world feel great through the power of better health, because how you feel in your body and mind transforms how you show up in life. No two people are the same, so we provide access to personalized care designed for results. Founded in 2017 and listed on the NYSE (HIMS) since January 2021, Hims & Hers offers access to care across the United States, Canada, Australia, Japan, the United Kingdom, France, and Spain.

Zocdoc is the healthcare access infrastructure that connects patients to great care. By powering seamless scheduling wherever patients are seeking care, Zocdoc helps them move from being stuck to being seen. Each month, millions of patients find and book appointments with providers, powered by Zocdoc—on the company’s website and app, and across online search, insurance directories, providers’ websites, practice phone lines, AI platforms, and more—with the typical appointment happening within 24 to 72 hours from booking. With nearly two decades of experience unifying healthcare’s fragmentation, Zocdoc is uniquely positioned to power access across insurance plans, EHRs and PMS systems, specialties, visit types, and provider organizations of every size. By fixing healthcare at the start, Zocdoc empowers patients to get the care they need, when they need it, while delivering scaled patient growth providers can count on.

Maven Clinic is the world's largest virtual clinic for women and families on a mission to make healthcare work for all of us. Through Maven Enterprise, the company partners with more than 2,300 employers and health plans to provide end-to-end women's and family health programs spanning fertility and family building, maternity and newborn care, parenting and pediatrics, and menopause and midlife — improving clinical outcomes, reducing healthcare costs, and expanding equitable access to high-quality care at scale. Through its consumer platform, Maven provides direct access to virtual care across 30+ specialties, as well as dedicated hormone and GLP-1 care programs purpose-built for women. Founded in 2014 by CEO Kate Ryder, Maven Clinic has raised more than $425 million from leading healthcare and technology investors including General Catalyst, Sequoia, Dragoneer Investment Group, Oak HC/FT, StepStone Group, Icon Ventures, and Lux Capital. Recognized for innovation and industry leadership, Maven has been named to the TIME100 Most Influential Companies, CNBC Disruptor 50, Fast Company's Most Innovative Companies, and FORTUNE Best Places to Work. Learn more at mavenclinic.com